Literature DB >> 33505813

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis.

Kheraj Mal1, Ratan Kumar2, Farah Mansoor3, Navneet Kaur4, Anil Kumar1, Sidra Memon3, Amber Rizwan5.   

Abstract

Introduction Rheumatoid arthritis is a chronic, inflammatory, and multisystem disease, which, along with the joints, can involve the cardiovascular system. The treatment of rheumatoid arthritis or rheumatoid arthritis itself can lead to atherosclerosis, which is considered one of the major causes by which it can affect the cardiovascular system. In this study, we will assess the risk of cardiovascular events in patients with rheumatoid arthritis as compared to the general population. Method This case-control study was conducted from January 2018 to November 2018. Two-hundred twenty-two (222) patients with diagnosed rheumatoid arthritis were included as cases in the study. Two-hundred eleven (211) patients were included in the study as the control group (patients without rheumatoid arthritis). All the data were recorded in a self-structured questionnaire. Result Participants with rheumatoid arthritis also showed an increased risk of myocardial infarction (MI) by an odds ratio of 2.50 (95% CI; 0.77-8.14). There was also an increased risk of cardiovascular death in participants with rheumatoid arthritis by an odds ratio of 1.99 (0.58-6.71). Conclusion The study suggests that rheumatoid arthritis along with joint inflammation can also affect the cardiovascular system. Hence, a multidisciplinary team of rheumatologists and cardiologists should manage patients suffering from rheumatoid arthritis, which will improve morbidity and mortality in such patients.
Copyright © 2020, Mal et al.

Entities:  

Keywords:  autoimmune diseases; cardiovascular events; myocardial infarction; rheumatoid arthritis

Year:  2020        PMID: 33505813      PMCID: PMC7823064          DOI: 10.7759/cureus.12246

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  24 in total

1.  Patterns of cardiovascular risk in rheumatoid arthritis.

Authors:  D H Solomon; N J Goodson; J N Katz; M E Weinblatt; J Avorn; S Setoguchi; C Canning; S Schneeweiss
Journal:  Ann Rheum Dis       Date:  2006-06-22       Impact factor: 19.103

2.  Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.

Authors:  Christina Charles-Schoeman; Yuen Yin Lee; Victor Grijalva; Sogol Amjadi; John FitzGerald; Veena K Ranganath; Mihaela Taylor; Maureen McMahon; Harold E Paulus; Srinivasa T Reddy
Journal:  Ann Rheum Dis       Date:  2012-01-20       Impact factor: 19.103

3.  High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.

Authors:  I D del Rincón; K Williams; M P Stern; G L Freeman; A Escalante
Journal:  Arthritis Rheum       Date:  2001-12

Review 4.  Cardiovascular disease in rheumatoid arthritis.

Authors:  Mariana J Kaplan
Journal:  Curr Opin Rheumatol       Date:  2006-05       Impact factor: 5.006

Review 5.  [Rheumatoid arthritis - an independent risk factor for cardiovascular disease].

Authors:  V Ráček; P Němec
Journal:  Vnitr Lek       Date:  2012-11

Review 6.  Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies.

Authors:  Christophe Meune; Emmanuel Touzé; Ludovic Trinquart; Yannick Allanore
Journal:  Rheumatology (Oxford)       Date:  2009-08-20       Impact factor: 7.580

Review 7.  Atherosclerosis: the interplay between lipids and immune cells.

Authors:  Frank Schaftenaar; Vanessa Frodermann; Johan Kuiper; Esther Lutgens
Journal:  Curr Opin Lipidol       Date:  2016-06       Impact factor: 4.776

Review 8.  Physical activity in patients with rheumatoid arthritis.

Authors:  Frank Verhoeven; Nicolas Tordi; Clément Prati; Céline Demougeot; Fabienne Mougin; Daniel Wendling
Journal:  Joint Bone Spine       Date:  2015-11-28       Impact factor: 4.929

Review 9.  Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Claire Rempenault; Bernard Combe; Thomas Barnetche; Cécile Gaujoux-Viala; Cédric Lukas; Jacques Morel; Charlotte Hua
Journal:  Ann Rheum Dis       Date:  2017-09-25       Impact factor: 19.103

Review 10.  Physical Exercise for Frailty and Cardiovascular Diseases.

Authors:  Natalia Aquaroni Ricci; Ana Izabel Lopes Cunha
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

View more
  1 in total

1.  Trends of adverse events and mortality after DMARDs in patients with rheumatoid arthritis: Interrupted time-series analysis.

Authors:  Yao-Fan Fang; Jia-Rou Liu; Shu-Hao Chang; Chang-Fu Kuo; Lai-Chu See
Journal:  Immun Inflamm Dis       Date:  2022-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.